SUOMEN PUNAINEN RISTI VERIPALVELU has a total of 67 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Finland. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are LSIP LLC, GDANSKI UNIV MEDYCZNY and CHANGCHUN WAN CHENG BIO ELECTRON CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 17 | |
#3 | Finland | 11 | |
#4 | United States | 6 | |
#5 | Australia | 5 | |
#6 | Canada | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | India | 2 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Macromolecular chemistry and polymers | |
#5 | Medical technology | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Peptides | |
#7 | Polysaccharides | |
#8 | Object sterilising | |
#9 | Foods | |
#10 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Natunen Jari | 22 |
#2 | Valmu Leena | 21 |
#3 | Partanen Jukka | 21 |
#4 | Satomaa Tero | 19 |
#5 | Maettoe Jaana | 16 |
#6 | Wacklin Pirjo | 14 |
#7 | Natunen Suvi | 14 |
#8 | Maekivuokko Harri | 14 |
#9 | Nystedt Johanna | 14 |
#10 | Laine Jarmo | 13 |
Publication | Filing date | Title |
---|---|---|
WO2012049369A1 | Marker for cells | |
FI20115976A0 | Use of a proteolytic enzyme | |
FI20115917A0 | Cells for cells | |
EP2598155A2 | Use of blood group status iii | |
FI20115613A0 | A method for characterizing human mesenchymal cells | |
WO2011157896A2 | Induced proteins | |
FI20115602A0 | Use of galectin | |
WO2011154615A1 | Method for isolating cd34+ hematopoietic stem cells, natural killer cells and regulatory t lymphocytes from a sample of human umbilical cord blood by using an anti-gd3 antibody, as well as compositions thereof | |
FI20106354A0 | A method for producing human retinal pigment epithelial cells | |
FI20106213A0 | Method of isolating cells and cell population isolated by the method | |
FI20105825A0 | Use of blood group status III | |
WO2011007049A1 | Use of animal cells for screening probiotic bacteria strains | |
FI20105670A0 | Use of ABO type | |
EP2384759A1 | Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells | |
AU2009305331A1 | Method of protecting cells | |
EP1904532A2 | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |